Fed. Circ. Again Eyes Ban On Lupin's Generic Fortamet
An order in a patent dispute barring Lupin Ltd. from selling its generic version of the diabetes drug Fortamet once again will be scrutinized by the Federal Circuit on Wednesday, two...To view the full article, register now.
Already a subscriber? Click here to view full article